Pritesh Shah
2021
In 2021, Pritesh Shah earned a total compensation of $5.5M as Chief Commercial Officer at NovoCure, a 7% decrease compared to previous year.
Compensation breakdown
| Option Awards | $1,664,746 |
|---|---|
| Salary | $500,000 |
| Stock Awards | $3,333,248 |
| Other | $8,900 |
| Total | $5,506,894 |
Shah received $3.3M in stock awards, accounting for 61% of the total pay in 2021.
Shah also received $1.7M in option awards, $500K in salary and $8.9K in other compensation.
Rankings
In 2021, Pritesh Shah's compensation ranked 2,325th out of 12,405 executives tracked by ExecPay. In other words, Shah earned more than 81.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,325 out of 12,405 | 81st |
Division Manufacturing | 908 out of 5,494 | 84th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 96 out of 798 | 88th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 61 out of 519 | 88th |
Industry Surgical and Medical Instruments and Apparatus | 40 out of 324 | 88th |
Source: SEC filing on April 25, 2022.
Shah's colleagues
We found four more compensation records of executives who worked with Pritesh Shah at NovoCure in 2021.